SLC38A3 and cancer: These findings raise the possibility that CAV1 controls glutamine uptake and utilisation in cancer by influencing SNAT3 or other amino acid transporters reviewed in [71, 72], and could lead to novel understanding of glutamine dependency in cancer cells.